BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 31124967)

  • 1. Analysis of the function of MAGE-A in esophageal carcinoma by bioinformatics.
    Chen X; Cai S; Wang L; Zhang X; Li W; Cao X
    Medicine (Baltimore); 2019 May; 98(21):e15774. PubMed ID: 31124967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decitabine enhances tumor recognition by T cells through upregulating the MAGE-A3 expression in esophageal carcinoma.
    Shi X; Chen X; Fang B; Ping Y; Qin G; Yue D; Li F; Yang S; Zhang Y
    Biomed Pharmacother; 2019 Apr; 112():108632. PubMed ID: 30797153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficient induction of anti-tumor immune response in esophageal squamous cell carcinoma via dendritic cells expressing MAGE-A3 and CALR antigens.
    Liu X; Song N; Liu Y; Liu Y; Li J; Ding J; Tong Z
    Cell Immunol; 2015 Jun; 295(2):77-82. PubMed ID: 25863743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual TGF-β and PD-1 blockade synergistically enhances MAGE-A3-specific CD8
    Chen X; Wang L; Li P; Song M; Qin G; Gao Q; Zhang Z; Yue D; Wang D; Nan S; Qi Y; Li F; Yang L; Huang L; Zhang M; Zhang B; Gao Y; Zhang Y
    Int J Cancer; 2018 Nov; 143(10):2561-2574. PubMed ID: 29981155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between the high expression levels of cancer-germline genes with clinical characteristics in esophageal squamous cell carcinoma.
    Chen X; Wang L; Yue D; Liu J; Huang L; Yang L; Cao L; Qin G; Li A; Wang D; Wang M; Qi Y; Zhang B; van der Bruggen P; Zhang Y
    Histol Histopathol; 2017 Aug; 32(8):793-803. PubMed ID: 27868181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value and functional bioinformatic analysis of spindle- and kinetochore-associated protein 1 in stage IIA esophageal squamous cell carcinoma.
    Hu D; Zhang M; Peng Z
    J Cancer Res Ther; 2020 Sep; 16(5):1157-1164. PubMed ID: 33004764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and characterization of prognosis-related genes in the tumor microenvironment of esophageal squamous cell carcinoma.
    Qu J; Zhao Q; Yang L; Ping Y; Zhang K; Lei Q; Liu F; Zhang Y
    Int Immunopharmacol; 2021 Jul; 96():107616. PubMed ID: 34162127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic modulation combined with PD-1/PD-L1 blockade enhances immunotherapy based on MAGE-A11 antigen-specific CD8+T cells against esophageal carcinoma.
    Wu Y; Sang M; Liu F; Zhang J; Li W; Li Z; Gu L; Zheng Y; Li J; Shan B
    Carcinogenesis; 2020 Jul; 41(7):894-903. PubMed ID: 32529260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MAGE-C3 promotes cancer metastasis by inducing epithelial-mesenchymal transition and immunosuppression in esophageal squamous cell carcinoma.
    Wu Q; Zhang W; Wang Y; Min Q; Zhang H; Dong D; Zhan Q
    Cancer Commun (Lond); 2021 Dec; 41(12):1354-1372. PubMed ID: 34347390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer-testis gene expression profiling in esophageal squamous cell carcinoma: identification of specific tumor marker and potential targets for immunotherapy.
    Forghanifard MM; Gholamin M; Farshchian M; Moaven O; Memar B; Forghani MN; Dadkhah E; Naseh H; Moghbeli M; Raeisossadati R; Abbaszadegan MR
    Cancer Biol Ther; 2011 Aug; 12(3):191-7. PubMed ID: 21613820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of microRNAs as novel biomarkers for esophageal squamous cell carcinoma: a study based on The Cancer Genome Atlas (TCGA) and bioinformatics.
    Li CY; Zhang WW; Xiang JL; Wang XH; Li J; Wang JL
    Chin Med J (Engl); 2019 Sep; 132(18):2213-2222. PubMed ID: 31490264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minichromosome maintenance 6 complex component identified by bioinformatics analysis and experimental validation in esophageal squamous cell carcinoma.
    Li X; Ren Z; Xiong C; Geng J; Li Y; Liu C; Ren C; Liu H
    Oncol Rep; 2020 Sep; 44(3):987-1002. PubMed ID: 32583000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Significance of MAGE-A11 in Esophageal Squamous Cell Carcinoma and Identification of Related Genes Based on DNA Microarray.
    Sang M; Gu L; Liu F; Lian Y; Yin D; Fan X; Ding C; Huang W; Liu S; Shan B
    Arch Med Res; 2016 Apr; 47(3):151-61. PubMed ID: 27362547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA‑200a promotes esophageal squamous cell carcinoma cell proliferation, migration and invasion through extensive target genes.
    Yang B; Liu Y; Li L; Deng H; Xian L
    Mol Med Rep; 2020 May; 21(5):2073-2084. PubMed ID: 32323771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive bioinformation analysis of methylated and differentially expressed genes in esophageal squamous cell carcinoma.
    Peng H; Wang S; Pang L; Yang L; Chen Y; Cui XB
    Mol Omics; 2019 Feb; 15(1):88-100. PubMed ID: 30706927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Demethylation-mediated upregulation of melanoma-associated antigen-A11 correlates with malignant progression of esophageal squamous cell carcinoma.
    Gu L; Sang M; Li J; Liu F; Wu Y; Liu S; Shan B
    Dig Liver Dis; 2019 Oct; 51(10):1475-1482. PubMed ID: 31155488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of candidate aberrantly methylated and differentially expressed genes in Esophageal squamous cell carcinoma.
    Han BA; Yang XP; Hosseini DK; Zhang P; Zhang Y; Yu JT; Chen S; Zhang F; Zhou T; Sun HY
    Sci Rep; 2020 Jun; 10(1):9735. PubMed ID: 32546690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of antigen-specific immune responses by dendritic cells transduced with a recombinant lentiviral vector encoding MAGE-A3 gene.
    Lin L; Wei J; Chen Y; Huang A; Li KK; Zhang W
    J Cancer Res Clin Oncol; 2014 Feb; 140(2):281-9. PubMed ID: 24322180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melanoma-associated antigens in esophageal adenocarcinoma: identification of novel MAGE-A10 splice variants.
    Lin J; Lin L; Thomas DG; Greenson JK; Giordano TJ; Robinson GS; Barve RA; Weishaar FA; Taylor JM; Orringer MB; Beer DG
    Clin Cancer Res; 2004 Sep; 10(17):5708-16. PubMed ID: 15355897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disease-associated bias in T helper type 1 (Th1)/Th2 CD4(+) T cell responses against MAGE-6 in HLA-DRB10401(+) patients with renal cell carcinoma or melanoma.
    Tatsumi T; Kierstead LS; Ranieri E; Gesualdo L; Schena FP; Finke JH; Bukowski RM; Mueller-Berghaus J; Kirkwood JM; Kwok WW; Storkus WJ
    J Exp Med; 2002 Sep; 196(5):619-28. PubMed ID: 12208877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.